|
18.07.25 - 20:09
|
Philips Hold (DPA-AFX)
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Philips auf "Hold" mit einem Kursziel von 22 Euro belassen. Nach dem schwachen Jahresstart habe der Medizintechnikkonzern für die am 29. Juli anstehenden Quartalszahlen eine Verbesserung in Aussicht ......
|
|
|
10.07.25 - 14:36
|
Hazeltree Reports: Global Short-Selling Intensity Spikes for Consumer Lifestyle and Tech Sectors (Business Wire)
|
|
Live Nation, Super Micro, Kering, Philips, ANTA Sports Products, and Nintendo appear among top-10 most crowded shorts across global regionsNEW YORK & LONDON--(BUSINESS WIRE)--The hedge fund market saw broad-based gains, continued inflows, and signs of strategic repositioning, as reflected in short-selling activity tracked in the Hazeltree June 2025 Shortside Crowdedness Report. Across all regions, short-sellers targeted consumer lifestyle and technology brands, according to Hazeltree, a leader in active treasury and intelligent operations technology for the alternative asset industry. Frequently shorted consumer discretionary names included Live Nation Entertainment, Inc., JetBlue Airways Corporation, Kering SA, LVMH Moët Hennessy, ANTA Sports Products Ltd., and Oriental Land Co., Ltd. Noteworthy tech targets included Super Micro Computer, Inc., Synopsys, Inc., Koninklijke Philips N.V., Nintendo Co., Ltd., and Hon Hai Precision Industry Co., Ltd.
The report is a monthly listing of the top 10 most crowded...
|
|
|
09.07.25 - 11:03
|
Endologix Announces that Scott Huennekens Joins Board of Directors (Business Wire)
|
|
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that R. Scott Huennekens has been appointed to the Endologix Board of Directors.
Mr. Huennekens is a highly regarded medtech CEO, chairperson, entrepreneur and investor, serving an impressive list of companies. Previously, he led Volcano Corp. (VOLC), a leader in minimally invasive therapy guidance in interventional cardiology, from start-up in 2002 to IPO to its sale to Philips in 2015. He was awarded E&Y's entrepreneur of the year award in 2010 and was recognized by Goldman Sachs in 2016, 2017, & 2018 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference. Mr. Huennekens graduated magna cum laude with a BS in Business Administration from the University of Southern California and holds his MBA from the Harvard Business School.
“We are delighted to a...
|
|
07.07.25 - 13:18
|
Philips Hold (DPA-AFX)
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Philips mit einem Kursziel von 22 Euro auf "Hold" belassen. Chinesische Sanktionen gegen Medizinprodukte aus der EU hätten nur geringe Auswirkungen auf die von ihm beobachteten europäischen Medizintechnikhersteller, ......
|
|
07.07.25 - 08:09
|
Philips Buy (DPA-AFX)
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Philips mit einem Kursziel von 26 Euro auf "Buy" belassen. Das zweite Quartal dürfte die Wende für Ergebnisentwicklung und auch Stimmungslage bringen, schrieb Graham Doyle in ......
|
|
|
|
27.06.25 - 11:45
|
Philips Buy (DPA-AFX)
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Philips auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt, schrieb Graham Doyle in einer am Freitag vorliegenden ......
|
|
26.06.25 - 08:24
|
Philips Overweight (DPA-AFX)
|
|
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Philips von 28,00 auf 27,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Das zweite Quartal dürfte etwas besser gewesen sein als der Jahresauftakt, ......
|
|
24.06.25 - 08:39
|
Philips Neutral (DPA-AFX)
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Philips mit einem Kursziel von 15,30 Euro auf "Neutral" belassen. Die Ausgangslage sei gegenüber dem ersten Quartal unverändert, schrieb David Adlington in seinem am Dienstag vorliegenden ......
|
|
|
20.06.25 - 10:51
|
Philips Buy (DPA-AFX)
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Philips mit einem Kursziel von 26 Euro auf "Buy" belassen. Die Niederländer seien das Unternehmen im europäischen Medtech-Bereich, bei denen sich die Investoren besonders einig ......
|
|
|
|
|
05.06.25 - 15:03
|
PaceMate® Names JR Finkelmeier CEO As It Sets Its Sights on Large-Scale Expansion (Business Wire)
|
|
Founding CEO Tripp Higgins To Become Chairman of the Board of Directors, Supporting the Leadership Transition As Finkelmeier Puts Operational Structure in Place to Meet Growing DemandSARASOTA, Fla.--(BUSINESS WIRE)--PaceMate, the cardiac remote monitoring platform that leading healthcare providers trust, today announced the appointment of JR Finkelmeier as Chief Executive Officer (CEO). Finkelmeier joined PaceMate as Chief Commercial Officer in 2024, after years leading Philips' multi-hundred-million-dollar ambulatory monitoring division. As CEO of PaceMate, he will lead the company through operational transformation in support of plans for significant commercial expansion. Finkelmeier succeeds founding CEO Tripp Higgins, who will become the Chairman of the Board of Directors.
Since its founding 10 years ago, PaceMate has achieved widespread adoption by healthcare providers like Duke Health, Advocate Health and many others. In 2024, PaceMate acquired Medtronic's PaceArt Optima™ system, adding nearly 1...
|
|
05.06.25 - 12:03
|
Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people (GlobeNewswire EN)
|
|
Amsterdam, the Netherlands – Marking its tenth anniversary, Philips Foundation today released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around the world – a significant increase from 28 million the year before. This progress was driven by 22 new initiatives and five new early-stage capital impact investments that expanded Philips Foundation's reach, channeling Philips' health technology expertise to help address the growing burden of non-communicable diseases and maternal health challenges, predominantly at the primary care level in underserved communities. “Today, half of the global population still does not have access to healthcare. Innovation and new digital technologies, combined with an ecosystem of partners, can improve health outcomes and make progress towards a future where quality healthcare is within reach for everyone,” said Marnix van Ginneken, Chair of the Board of the Philips...
|
|
|